COM:PRIMEMEDICINE
Prime Medicine, Inc.
- Stock
Last Close
1.91
13/03 20:00
Market Cap
666.17M
Beta: -
Volume Today
2.04M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 842.50K - | 2.88M 242.26% | 11.93M 313.89% | |||
average receivables | ||||||
book value per share | 0.00 - | 0.47 3,213,240.89% | 3.34 615.66% | -8.66 359.61% | 1.46 116.89% | |
capex per share | -0.01 - | -0.06 549.45% | -0.47 721.58% | -0.10 79.81% | ||
capex to depreciation | -14.86 - | -7.31 50.83% | -7.24 0.95% | -7.01 3.17% | ||
capex to operating cash flow | 0.12 - | 0.12 5.64% | 0.12 0.27% | 0.05 56.80% | ||
capex to revenue | -0.12 - | -3.09 - | ||||
cash per share | 0.00 - | 0.74 822,220.79% | 3.76 405.59% | 8.67 130.93% | 1.28 85.27% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 0.03 - | 0.08 131.42% | 0.07 11.85% | |||
debt to equity | 0.04 - | -0.10 325.41% | 0.10 204.63% | |||
dividend yield | ||||||
earnings yield | -0.00 - | -0.00 79.79% | -0.15 4,749.47% | -0.19 29.10% | -0.25 27.07% | |
enterprise value | 1.47B - | 1.07B 27.51% | 928.48M 12.94% | 470.82M 49.29% | 778.05M 65.25% | |
enterprise value over ebitda | -677.42 - | -90.72 86.61% | -11.12 87.75% | -4.34 60.94% | -3.80 12.52% | |
ev to operating cash flow | -1.10K - | -192.37 82.56% | -27.24 85.84% | -3.57 86.89% | -4.70 31.70% | |
ev to sales | 204.71 - | 90.37 - | ||||
free cash flow per share | -0.01 - | -0.09 518.01% | -0.53 518.34% | -4.36 719.63% | -1.91 56.14% | |
free cash flow yield | -0.00 - | -0.01 518.01% | -0.03 518.34% | -0.23 578.02% | -0.22 8.03% | |
graham net net | 0.00 - | 0.45 3,188,342.74% | 2.89 547.50% | -1.96 167.84% | 0.61 131.11% | |
graham number | 0.00 - | 0.71 23,935.71% | 13.15 1,762.95% | 26.47 101.28% | 8.47 68.01% | |
income quality | 0.53 - | 1.63 208.22% | 0.21 87.32% | 1.08 425.06% | 0.83 22.85% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -9.61 - | |||||
interest debt per share | 0.14 - | 1.21 732.09% | 0.15 87.57% | |||
inventory turnover | ||||||
invested capital | 0.04 - | -0.10 325.41% | 0.10 204.63% | |||
market cap | 1.47B - | 1.10B 25.00% | 1.10B 0% | 629.70M 42.94% | 805.99M 28.00% | |
net current asset value | 1.39K - | 32.09M 2,310,411.16% | 208.28M 549.00% | -66.39M 131.88% | 82.20M 223.80% | |
net debt to ebitda | 0.00 - | 3.15 78,902.89% | 2.10 33.37% | 1.47 30.07% | 0.14 90.69% | |
net income per share | -0.03 - | -0.05 79.79% | -2.30 4,749.47% | -3.59 56.06% | -2.18 39.41% | |
operating cash flow per share | -0.01 - | -0.08 454.14% | -0.47 514.75% | -3.89 719.39% | -1.82 53.25% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | 0.57 - | 16.65 - | ||||
return on tangible assets | -290.79 - | -0.06 99.98% | -0.55 780.12% | -0.34 38.28% | -1.02 202.31% | |
revenue per share | 0.07 - | 0.15 - | ||||
roe | -1.82K - | -0.10 99.99% | -0.69 577.62% | 0.41 160.11% | -1.49 458.82% | |
roic | -1.57K - | -0.06 100.00% | -0.32 425.72% | 0.49 251.42% | -1.28 361.12% | |
sales general and administrative to revenue | 0.61 - | 5.72 - | ||||
shareholders equity per share | 0.00 - | 0.47 3,213,240.89% | 3.34 615.66% | -8.66 359.61% | 1.46 116.89% | |
stock based compensation to revenue | 0.08 - | 1.24 - | ||||
tangible asset value | 1.39K - | 33.47M 2,409,835.21% | 239.56M 615.66% | 133.07M - | ||
tangible book value per share | 0.00 - | 0.47 3,213,240.89% | 3.34 615.66% | 1.46 - | ||
working capital | 1.39K - | 33.96M 2,444,824.41% | 212.60M 526.02% | 267.21M 25.69% | 86.55M 67.61% |
All numbers in USD (except ratios and percentages)